Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznań, Poland.
Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland.
Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26266. Epub 2016 Oct 19.
We report a pediatric case of acute T-lymphoblastic leukemia (T-ALL) with NOTCH1 , FBXW7 , STIL/TAL1, and PTEN (exons 2, 3, 4, 5) monoallelic deletions, biallelic CDKN2A/B deletion, and a minor t(8;14)(q24;q11)-positive subclone. Undetectable by a flow cytometric minimal residual disease assay, the t(8;14)(q24;q11) subclone expanded as detected by fluorescence in situ hybridization from 5% at diagnosis to 26% before consolidation and 100% at relapse bearing a monoallelic deletion (exons 2, 3) with a new frameshift mutation of PTEN and the same set of remaining molecular alterations. This case documents an unfavorable prognostic potential of a co-occurrence of this set of molecular genetic events and addresses risk stratification in T-ALL.
我们报告了一例小儿急性 T 淋巴细胞白血病(T-ALL)病例,该病例存在 NOTCH1、FBXW7、STIL/TAL1 和 PTEN(外显子 2、3、4、5)单等位基因缺失、双等位基因 CDKN2A/B 缺失,以及一个小的 t(8;14)(q24;q11)阳性亚克隆。该亚克隆通过流式细胞术微小残留病检测无法检测到,但通过荧光原位杂交检测,在诊断时为 5%,在巩固前为 26%,在复发时为 100%,并伴有单等位基因缺失(外显子 2、3),PTEN 出现新的移码突变,同时伴有一组剩余的分子改变。该病例记录了这一组分子遗传事件的同时发生具有不良预后潜力,并解决了 T-ALL 的风险分层问题。